Gamma synuclein is a novel Twist1 target that promotes TGF-β-induced cancer cell migration and invasion.
Ting ShaoPeiying SongHui HuaHongying ZhangXiangmin SunQingbin KongJiao WangTing LuoYangfu JiangPublished in: Cell death & disease (2018)
Transforming growth factor β (TGF-β) is critical for embryonic development, adult tissue homeostasis, and tumor progression. TGF-β suppresses tumors at early stage, but promotes metastasis at later stage through oncogenes such as Twist1. Gamma-synuclein (SNCG) is overexpressed in a variety of invasive and metastatic cancer. Here, we show that TGF-β induces SNCG expression by Smad-Twist1 axis, thus promoting TGF-β- and Twist1-induced cancer cell migration and invasion. We identify multiple Twist1-binding sites (E-boxes) in SNCG promoter. Chromatin immunoprecipitation and luciferase assays confirm the binding of Twist1 to the E-boxes of SNCG promoter sequence (-129/-1026 bp). Importantly, the Twist1-binding site close to the transcription initiation site is critical for the upregulation of SNCG expression by TGF-β and Twist1. Mutations of Twist1 motif on the SNCG promoter constructs markedly reduces the promoter activity. We further show that TGF-β induces Twist1 expression through Smad thereby enhancing the binding of Twist1 to SNCG promoter, upregulating SNCG promoter activity and increasing SNCG expression. SNCG knockdown abrogates TGF-β- or Twist1-induced cancer cell migration and invasion. Finally, SNCG knockdown inhibits the promotion of cancer metastasis by Twist1. Together, our data demonstrate that SNCG is a novel target of TGF-β-Smad-Twist1 axis and a mediator of Twist1-induced cancer metastasis.
Keyphrases
- transforming growth factor
- epithelial mesenchymal transition
- signaling pathway
- poor prognosis
- dna methylation
- transcription factor
- gene expression
- early stage
- high glucose
- small cell lung cancer
- drug induced
- cell proliferation
- long non coding rna
- young adults
- squamous cell
- dna damage
- data analysis
- neoadjuvant chemotherapy